Related Experiment Video
Updated: Dec 5, 2025

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Challenges and solutions to nicotine replacement therapy access: observations from SCIMITAR
Catherine E Arundel1, Emily Peckham1, Della Bailey1
1Department of Health Sciences, University of York, UK.
Access to nicotine replacement therapy (NRT) for smoking cessation is difficult for patients, particularly those with severe mental ill health. Simplifying and improving NRT accessibility is crucial for enhancing quit rates.
Area of Science:
- Public Health
- Mental Health Research
- Addiction Medicine
Background:
- Smoking cessation is vital for physical and mental health.
- National Institute for Health and Care Excellence (NICE) guidelines recommend support, nicotine products, and cessation services.
- Reducing tobacco harm is a key public health objective.
Purpose of the Study:
- To explore challenges in accessing smoking cessation support, specifically nicotine replacement therapy (NRT).
- To identify difficulties in NRT provision for patients with severe mental ill health.
- To suggest improvements for facilitating NRT access and provision.
Main Methods:
- Analysis of data from the Smoking Cessation Intervention for Severe Mental Ill Health Trial (SCIMITAR+).
- Identification of barriers to NRT access and provision across various study settings.
- Collating strategies used to improve NRT facilitation.
Main Results:
- NRT access varied significantly across settings and was sometimes impossible for patients.
- Difficulties in accessing NRT were not exclusive to patients with severe mental ill health.
- NRT provision did not consistently adhere to NICE guidelines.
Conclusions:
- Smoking cessation support and NRT availability require clearer, simpler, and more accessible pathways.
- Improved accessibility of NRT is essential for increasing smoking cessation success rates.
- Addressing systemic barriers to NRT provision can enhance public health outcomes.
More Related Videos
10:44Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drug Dependence
CNS Depressants: Alcohol and Nicotine
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Acute Coronary Syndrome IV: Interprofessional Care